Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Global Network of CLL Advocacy Organizations (CLLAN) Releases a White Paper Addressing CLL Immune-Related Challenges

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

CLL Society is proud to be a member of the CLL Advocates Network (CLLAN). This global network of CLL patient advocate organizations, in partnership with AstraZeneca, released the White Paper, Compromised: Uncovering the immune-related challenges facing people with chronic lymphocytic leukaemia.

CLL Society remains committed to advocating for the needs of those who are considered immunocompromised. This includes all of those diagnosed with CLL or SLL, regardless of their treatment status.